Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.54 |
| ▸ | LCK | P06239 | 1/20 | 0.54 |
| ▸ | FYN | P06241 | 1/20 | 0.54 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 2/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL28271586 | 0.96 | FFAR3 (0.50) | FFAR3LCKFYNSLC34A1CA4 | |
| Phosphoric Acid SCHEMBL3001932 | 0.92 | FFAR3 (0.54) | FFAR3LCKFYNSLC34A1CA4 | |
| Phosphoric Acid SCHEMBL28282273 | 0.92 | FFAR3 (0.54) | FFAR3LCKFYNSLC34A1CA4 | |
| Phosphoric Acid SCHEMBL27606778 | 0.92 | FFAR3 (0.54) | FFAR3LCKFYNSLC34A1CA4 | |
| Phosphoric Acid SCHEMBL11339920 | 0.92 | FFAR3 (0.54) | FFAR3LCKFYNSLC34A1CA4 | |
| Phosphoric Acid SCHEMBL28402400 | 0.92 | FFAR3 (0.54) | FFAR3LCKFYNSLC34A1CA4 | |
| Phosphoric Acid SCHEMBL540831 | 0.92 | FFAR3 (0.54) | FFAR3LCKFYNSLC34A1CA4 | |
| Phosphoric Acid SCHEMBL4743957 | 0.92 | FFAR3 (0.54) | FFAR3LCKFYNSLC34A1CA4 | |
| Phosphoric Acid SCHEMBL28049822 | 0.89 | SLC34A1 (0.64) | FFAR3LCKFYNSLC34A1CA4 | |
| Phosphoric Acid SCHEMBL28309432 | 0.89 | FFAR3 (0.50) | FFAR3LCKFYNSLC34A1CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101580878-B | Molecular marker for distinguishing soluble acid invertase allelic variation sweet sorghum material | INST CROP SCIENCE CAAS | 2011-09-28 | — | — | CN | disclosed |
| US-20110223156-A1 | REVERSIBLE GEL PROTEIN FORMULATION | AMGEN INC. | 2011-09-15 | — | — | US | disclosed |
| US-20100056765-A1 | Formulations That Inhibit Protein Aggregation | AMGEN INC. (US) | 2010-03-04 | — | — | US | disclosed |
| CN-101580878-A | Molecular marker for distinguishing soluble acid invertase allelic variation sweet sorghum material | INST CROP SCIENCE CAAS (CN) | 2009-11-18 | — | — | CN | disclosed |
| EP-1909838-A2 | FORMULATIONS THAT INHIBIT PROTEIN AGGREGATION | AMGEN INC. (US) | 2008-04-16 | — | — | EP | disclosed |
| US-20070190047-A1 | FORMULATIONS THAT INHIBIT PROTEIN AGGREGATION | AMGEN, INC. | 2007-08-16 | — | — | US | disclosed |
| WO-2007016562-A9 | FORMULATIONS THAT INHIBIT PROTEIN AGGREGATION | AMGEN INC (US) | 2007-05-24 | — | — | WO | disclosed |
| WO-2007016562-A2 | FORMULATIONS THAT INHIBIT PROTEIN AGGREGATION | AMGEN INC. (US) | 2007-02-08 | — | — | WO | disclosed |